To main content To main navigation
GIANTT

Groningen Initiative to ANalyse Type 2 diabetes Treatment (GIANTT)

Groningen initiative to analyse type 2 diabetes treatment. Cohort
Groningen initiative to analyse type 2 diabetes treatment.
The GIANTT project collects data from people with type 2 diabetes from a large number of general practices in the Groningen region.

A one-size-fits-all approach is not appropriate to treat diabetes. Individualized treatment is required, often including multiple medications to manage risk factors and prevent cardiovascular and renal complications. The GIANTT database provides insight into the treatment patterns and the outcomes of treatment in the Dutch primary care setting.

GIANTT aims to support research focusing on the assessment and improvement of the quality and outcomes of treatment among patients with type 2 diabetes managed in Dutch primary care. 

  • Patients who have been diagnosed with type 2 diabetes as documented in the electronic medical records of participating general practices. All general practices in the Groningen region have been asked to participate and over the years the number of participating general practices has fluctuated between 40-180.


  • Please visit the UMCG Research Data Catalogue for more detailed information on our data and samples. 

    GIANTT contains 4 main tables with the following data: 

    • patient variables (age, sex, height, weight, smoking status); 
    • diagnoses and diabetes-related interventions (ICPC codes and text-derived); 
    • medication prescriptions (ATC codes, dosage); 
    • lab and physical examination results (e.g. blood pressure, kidney function, HbA1c level). 

    • Rijksuniversiteit Groningen
    • Diabetes Vereniging Nederland, region Groningen 
    • General Practitioners, region Groningen 
    • Martini Ziekenhuis (Department of Internal Medicine)

  • Please visit the GIANTT website for more information.


Relevance

How GIANTT benefits to society

The GIANTT database is unique in terms of providing longitudinal data for a dynamic, cumulative cohort of more than 50.000 patients who are treated for type 2 diabetes in Dutch primary care settings. Since 2004, routinely available data are being collected from the electronic medical records held by a large number of general practices in the Groningen region. These include information about age, sex, prescribed medication, outcomes of diagnostic measurements, and comorbidity as documented in the primary care setting. 

Contact

Small profile picture of P. Denig
Petra Denig Professor Drug Utilization Quality

University Medical Center Groningen (UMCG) 
Department of Clinical Pharmacy and Pharmacology (GIANTT)
PO Box 30.001 
9700 RB Groningen 
The Netherlands 

Visiting address 
University Medical Center Groningen (UMCG) 
Department of Clinical Pharmacy and Pharmacology 
Visiting address 
Hanzeplein 1 
9713 GZ Groningen 

Location: Entrance 45, 1st floor, Room 50.1.C1.014 

See also: Department UMCG Clinical Pharmacy and Pharmacology